MOLEMPATHY · Molecular mechanism of empathy
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2011-07-01 → 2013-06-30
- Финансиране от ЕС
- 230 980 €
- Участници
- 1
- Схема
- MC-IEF
Линиите свързват координатора с партньорите.
Накратко на български
Молекулярните механизми на емпатията се проучват чрез наблюдение на поведението на мишки, третирани с определени вещества. Разбирането на тези процеси в мозъка помага при изследването на състояния като аутизъм, тревожност и посттравматично стресово разстройство.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Molecular mechanism of empathy
Empathy plays a crucial social role, allowing the sharing of experiences, needs, and goals across individuals. Anxiety, posttraumatic stress disorder, autism spectrum disorders, Asperger’s syndrome and some cerebral damage are often characterized by an inability to empathize with others. Multiple behavioral studies claim that empathy is not restricted to humans, and even rodents have been shown to demonstrate empathy-like behavior, however molecular mechanism of social behavior is still poorly understood. The present study was aimed to investigate the signal transduction pathways in brain involved in empathy. We have used an animal model based in mice acutely treated with empathogens-entactogens, pharmacological agents that produce loss of social inhibitions and closeness in humans and induce analogous prosocial and anti-aggressive effects in laboratory animals. Our experiments revealed that even single administration of N-Methyl-3,4-methylenedioxyamphetamine [MDMA, “Ecstasy”] at low dose 3 mg/kg has binary effect on behavior of mice: in some animals MDMA promotes sociability without hyperlocomotion, whereas in other mice it elevates locomotor activity without affecting sociability. Both WAY-100635, a selective antagonist of 5-HT1A receptor, and L-368899, a selective oxytocin receptor antagonist, are capable to abolish prosocial effects of MDMA. Differential quantitative analysis of brain proteome by iTRAQ technology revealed 21 proteins, highly correlating with sociability, and allowed to distinguish between entactogenic and hyperlocomotive effects of MDMA on proteome level. Multiple alterations in pathways involved in energy maintenance (Glycolysis, Sugar metabolism; Oxidative phosphorylation, Dopaminergic signaling) have been detected. Another important pathway found to be related to sociability, is gamma-aminobutyric acid [GABA] signaling. Other overrepresented pathways include GPCR signaling, synaptic vesicle cycle, WNT signaling and regulation of protein turnover (transcription, translation, modification of proteins and their proteasomal degradation). Several important post-synaptic proteins are found to be differentially expressed. In general, identified sets of differentially expressed proteins for three analyzed brain regions (cerebral cortex, hippocampus and amygdala) are quite distinct, what represents the differences in their functions, and allows hypothesizing that there are several region-specific neuronal mechanisms of prosocial behavior. Functional association network for differentially expressed proteins in cerebral cortex, hippocampus and amygdala were identified. These data may help to discover new pharmacological and genetical tools for the modulation of social behavior, but in contrast to existing entactogens, will be suitable for long-term treatment of patients suffering from social fear and low sociability.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Empathy plays a fundamental social role, allowing the sharing of experiences, needs, and goals across individuals. Anxiety, posttraumatic stress disorder, autism, Asperger's syndrome and some cerebral damage are often characterised by an inability to empathise with others. Some studies of animal behaviour claim that empathy is not restricted to humans, and even rodents have been shown to demonstrate empathy for cagemates in pain. It is very likely that pro-social behaviour has neurological and neurochemical basis. Although recent fMRI studies on humans revealed that experience of empathy connected with activity of several regions in cerebral cortex, the molecular mechanism of empathy is still poorly understood. The current project is aimed to study the signal transduction pathways in brain involved in empathy. Given the intrinsic difficulties associated with such studies in human beings, here it is proposed to use an animal model, namely mice acutely treated with low dose of empathogens-entactogens, pharmacological agents that able to increase empathy, emotional sensitivity, loss of social inhibitions, reduced anxiety and an increased sense of closeness with other. Alteration in gene/protein expression profile of mouse cerebral cortex after single administration of widely used empathogen 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine will be investigated by methods of differential transcriptomics and proteomics. The co-administration of selective antagonists for 5-HT1a and oxytocin receptors, have been reported to regulate pro-social behaviour, will allow to distinguish between empathogenic and adverse effect of 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine. This study will further improve our knowledge about molecular mechanisms of empathy, and, possibly, may assist in elimination of side effects of existing empathogens-entactogens and in developing of therapies for patients suffering from specific neuronal pathologies.""
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSIDAD POMPEU FABRA · BarcelonaКоординаторИспания
Връзки
Данни: CORDIS, © Европейски съюз
